HIV Citation List: July 19 - August 1, 2013

PubMed citations

1. P2' Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Non-peptidic HIV-1 Protease Inhibitors Containing P2 Bis-tetrahydrofuran Moiety. Yedidi, R.S., K. Maeda, W.S. Fyvie, M. Steffey, D.A. Davis, I. Palmer, M. Aoki, J.D. Kaufman, S.J. Stahl, H. Garimella, D. Das, P.T. Wingfield, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23877703].

[PubMed]. HIV_0719-080113.

2. Bispecific Antibodies Directed to CD4 Domain 2 and HIV Envelope Exhibit Exceptional Breadth and Picomolar Potency against HIV-1. Pace, C.S., R. Song, C. Ochsenbauer, C.D. Andrews, D. Franco, J. Yu, D.A. Oren, M.S. Seaman, and D.D. Ho. Proceedings of the National Academy of Sciences of the United States of America, 2013. [Epub ahead of print]. PMID[23878231].

[PubMed]. HIV_0719-080113.

3. Identification of Hck Inhibitors as Hits for the Development of Antileukemia and anti-HIV Agents. Tintori, C., I. Laurenzana, F. La Rocca, F. Falchi, F. Carraro, A. Ruiz, J.A. Este, M. Kissova, E. Crespan, G. Maga, M. Biava, C. Brullo, S. Schenone, and M. Botta. ChemMedChem, 2013. 8(8): p. 1353-1360. PMID[23813855].

[PubMed]. HIV_0719-080113.

4. Molecular Docking Guided Structure Based Design of Symmetrical N,N'-Disubstituted Urea/Thiourea as HIV-1 gp120-CD4 Binding Inhibitors. Sivan, S.K., R. Vangala, and V. Manga. Bioorganic & Medicinal Chemistry, 2013. 21(15): p. 4591-4599. PMID[23777826].

[PubMed]. HIV_0719-080113.

5. Synthesis and Antiviral Activities of Methylenecyclopropane Analogs with 6-Alkoxy and 6-Alkylthio Substitutions That Exhibit Broad-spectrum Antiviral Activity against Human Herpesviruses. Prichard, M.N., J.D. Williams, G. Komazin-Meredith, A.R. Khan, N.B. Price, G.M. Jefferson, E.A. Harden, C.B. Hartline, N.P. Peet, and T.L. Bowlin. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3518-3527. PMID[23669381].

[PubMed]. HIV_0719-080113.

6. Multimerized CHR-derived Peptides as HIV-1 Fusion Inhibitors. Nomura, W., C. Hashimoto, T. Suzuki, N. Ohashi, M. Fujino, T. Murakami, N. Yamamoto, and H. Tamamura. Bioorganic & Medicinal Chemistry, 2013. 21(15): p. 4452-4458. PMID[23800723].

[PubMed]. HIV_0719-080113.

7. Cell-permeable Stapled Peptides Based on HIV-1 Integrase Inhibitors Derived from HIV-1 Gene Products. Nomura, W., H. Aikawa, N. Ohashi, E. Urano, M. Metifiot, M. Fujino, K. Maddali, T. Ozaki, A. Nozue, T. Narumi, C. Hashimoto, T. Tanaka, Y. Pommier, N. Yamamoto, J.A. Komano, T. Murakami, and H. Tamamura. ACS Chemical Biology, 2013. [Epub ahead of print]. PMID[23898787].

[PubMed]. HIV_0719-080113.

8. Synthesis and Biological Evaluation of 5-Fluoroquinolone-3-carboxylic Acids as Potential HIV-1 Integrase Inhibitors. He, Q.Q., X. Zhang, L.M. Yang, Y.T. Zheng, and F. Chen. Journal of Enzyme Inhibition and Medicinal Chemistry, 2013. 28(4): p. 671-676. PMID[22468749].

[PubMed]. HIV_0719-080113.

9. Hypericum Hircinum L. Components as New Single-molecule Inhibitors of Both HIV-1 Reverse Transcriptase-associated DNA Polymerase and Ribonuclease H Activities. Esposito, F., C. Sanna, C. Del Vecchio, V. Cannas, A. Venditti, A. Corona, A. Bianco, A.M. Serrilli, L. Guarcini, C. Parolin, M. Ballero, and E. Tramontano. Pathogens and Disease, 2013. 68(3): p. 116-124. PMID[23821410].

[PubMed]. HIV_0719-080113.

ISI Web of Knowledge Citations

10. Synthesis and anti-HIV Activity of Triazolo-fused 3 ',4 '-Cyclic and 4 '-Spiro Nucleoside Analogues. Sun, J.B., R.W. Liu, L.L. Xuan, W.C. Leng, and J.C. Wu. Chemical Research in Chinese Universities, 2013. 29(3): p. 473-476. ISI[000320296900015].

[WOS]. HIV_0719-080113.

11. A Novel anti-HIV Active Integrase Inhibitor with a Favorable in Vitro Cytochrome P450 and Uridine 5 '-Diphospho-glucuronosyltransferase Metabolism Profile. Okello, M.O., S. Mishra, M. Nishonov, M.K. Mankowski, J.D. Russell, J.Y. Wei, P.A. Hogan, R.G. Ptak, and V. Nair. Antiviral Research, 2013. 98(3): p. 365-372. ISI[000320296400002].

[WOS]. HIV_0719-080113.

12. The Utility of Self-emulsifying Oil Formulation to Improve the Poor Solubility of the Anti HIV Drug CSIC. Obitte, N.C., L.C. Rohan, C.M. Adeyeye, M.A. Parniak, and C.O. Esimone. AIDS research and therapy, 2013. 10. ISI[000320157400001].

[WOS]. HIV_0719-080113.

13. Two New Tryptophan Derivatives from the Seed Kernels of Entada rheedei: Effects on Cell Viability and HIV Infectivity. Nzowa, L.K., R.B. Teponno, L.A. Tapondjou, L. Verotta, Z. Liao, D. Graham, M.C. Zink, and L. Barboni. Fitoterapia, 2013. 87: p. 37-42. ISI[000319953100007].

[WOS]. HIV_0719-080113.

14. Size Matters, So Does Shape: Inhibition of Transcription of T7 RNA Polymerase by Iron(II) Clathrochelates. Novikov, V.V., O.A. Varzatskii, V.V. Negrutska, Y.N. Bubnov, L.G. Palchykovska, I.Y. Dubey, and Y.Z. Voloshin. Journal of Inorganic Biochemistry, 2013. 124: p. 42-45. ISI[000320087100006].

[WOS]. HIV_0719-080113.

15. Inhibitory Activity of Avicennia marina, a Medicinal Plant in Persian Folk Medicine, against HIV and HSV. Namazi, R., R. Zabihollahi, M. Behbahani, and A. Rezaei. Iranian Journal of Pharmaceutical Research, 2013. 12(2): p. 435-443. ISI[000320508300022].

[WOS]. HIV_0719-080113.

16. A New Chimeric Protein Represses HIV-1 LTR-mediated Expression by DNA Methylase. Martinez-Colom, A., S. Lasarte, A. Fernandez-Pineda, M. Relloso, and M.A. Munoz-Fernandez. Antiviral research, 2013. 98(3): p. 394-400. ISI[000320296400006].

[WOS]. HIV_0719-080113.

17. Synthesis of a Long Acting HIV Protease Inhibitor Via Metal or Enzymatic Reduction of the Appropriate Chloro Ketone and Selective Zinc Enolate Condensation with an Amino Epoxide. Houpis, I.N., R.M. Liu, L. Liu, Y.F. Wang, N.F. Dong, X.A. Zhao, Y. Zhang, T.T. Xiao, Y.C. Wang, D. Depre, U. Nettekoven, M. Vogel, R. Wilson, and S. Collier. Advanced Synthesis & Catalysis, 2013. 355(9): p. 1829-1839. ISI[000320275600020].

[WOS]. HIV_0719-080113.

18. Role of the Carbohydrate-binding Sites of Griffithsin in the Prevention of DC-SIGN-mediated Capture and Transmission of HIV-1. Hoorelbeke, B., J. Xue, P.J. LiWang, and J. Balzarini. PloS one, 2013. 8(5). ISI[000319799900016].

[WOS]. HIV_0719-080113.

19. Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer. Ehteshami, M., M. Nijhuis, J.A. Bernatchez, C.J. Ablenas, S. McCormick, D. de Jong, D. Jochmans, and M. Gotte. Journal of Biological Chemistry, 2013. 288(24): p. 17336-17346. ISI[000320380600027].

[WOS]. HIV_0719-080113.

20. Identification of a Human Protein-derived HIV-1 Fusion Inhibitor Targeting the gp41 Fusion Core Structure. Chao, L.J., L. Lu, H.W. Yang, Y. Zhu, Y. Li, Q. Wang, X.W. Yu, S.B. Jiang, and Y.H. Chen. PloS one, 2013. 8(5). ISI[000319799900240].

[WOS]. HIV_0719-080113.